000			01722cam a2200229 4500
001			9780323447980
008			220107t2017 xxu||||| |||| 00| 0 eng d
020			_a9780323447980
020			_a9780323447973
041			_aeng
100			_aWu, Jashin J.
245		0	_aTherapy for severe psoriasis
260			_aPhiladelphia : _bElsevier, _c2017
300			_a1 online resource (xi, 186 pages):illustrations (some color), color portraits
505			_aOverview of psoriasis -- Ultraviolet b phototherapy -- Psoralen-ultraviolet light a therapy -- Methotrexate -- Acitretin -- Cyclosporine -- Apremilast -- Etanercept -- Infliximab -- Adalimumab -- Ustekinumab -- Secukinumab -- Ixekizumab -- Biosimilars -- Combination therapies for psoriasis -- Investigational therapies for psoriasis.
520			_aA brand-new title in the field of dermatology, Therapy for Severe Psoriasis provides the ultimate coverage of the treatment options available for today's most serious cases, including biologics and oral therapies. It features discussions of the newest drug therapies, recent FDA-approved biosimilars, and combination approaches to care, while an overview chapter was designed to aid those new to the field in understanding the nuances of difficult-to-treat subtypes of psoriasis. Comprehensive and focused, Therapy for Severe Psoriasis will be a welcome addition to the library of any dermatologist seeking in-depth information on the challenges of this condition.
690			_aPsoriasis _97575
700			_aFeldman, Steven R.
700			_aLebwohl, Mark
856			_uhttps://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20150046226
999			_c57872 _d57872